12:00 AM
Dec 16, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Status

OTO-201: Phase III started

Otonomy began a pair of identical, double-blind, sham-controlled, North American Phase III trials to evaluate a single intratympanic injection of OTO-201 given in both ears in a total...

Read the full 116 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >